Anzeige
Mehr »
Freitag, 10.10.2025 - Börsentäglich über 12.000 News
Kursrakete 2025: CiTech präsentiert sich u.a. mit DroneShield neben Palantir & Rheinmetall - welche News sind zu erwarten?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D7B2 | ISIN: KYG6096M1226 | Ticker-Symbol: A1V0
NASDAQ
09.10.25 | 22:00
2,370 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
APTORUM GROUP LIMITED Chart 1 Jahr
5-Tage-Chart
APTORUM GROUP LIMITED 5-Tage-Chart

Aktuelle News zur APTORUM GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoAptorum Group Ltd: As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives6
MoAptorum Group Ltd - S-4, Registration of securities, business combinations1
03.10.Aptorum Group Ltd - 6-K, Report of foreign issuer1
10.09.Aptorum Group Ltd - 6-K, Report of foreign issuer1
22.08.Aptorum Group Stock Sinks After Hours Following 235% Thursday Surge3
21.08.Aptorum Group Stock Soars 159% On DiamiR Test Approval12
21.08.Why Is Nano-Cap Aptorum Stock Rallying On Thursday?2
21.08.Aptorum Group Ltd: DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test14
APTORUM GROUP Aktie jetzt für 0€ handeln
04.08.Aptorum Group Ltd: Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement315NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," "Aptorum" or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet...
► Artikel lesen
22.07.Aptorum Group Ltd - 6-K, Report of foreign issuer2
16.07.Aptorum Group Stock Soars 253% On Merger Deal With DiamiR Biosciences-
16.07.Aptorum To Merge With DiamiR In All-stock Deal, Stock Up In Pre-market11
16.07.Aptorum Group and Diamir Biosciences enter into merger agreement2
16.07.Aptorum Group Ltd: Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement279NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," "Aptorum" or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing unmet...
► Artikel lesen
30.04.Aptorum Group Ltd - 20-F, Annual and transition report of foreign private issuers2
16.04.Aptorum Group Ltd - 6-K, Report of foreign issuer1
16.04.Aptorum Group droht Delisting von der Nasdaq wegen Aktienkurs17
16.04.Aptorum Group Ltd: Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency706Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market...
► Artikel lesen
20.12.24Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024493NEW YORK--(BUSINESS WIRE)--Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1